A team of researchers from the Université de Montréal and the Centre hospitalier de l'Université de Montréal (CHUM) have announced an important breakthrough in fighting the human immunodeficiency virus (HIV). For the first time, scientists have identified a defect in the immune response to HIV and found a way to correct the flaw. Dr. Rafick-Pierre Sékaly, an eminent researcher in cell biology, immunology, and virology, has confirmed the identification of a new therapeutic target (the PD-1 protein) that restores the function of the T cells whose role is to eliminate cells infected with the virus. This constitutes a major breakthrough, opening new prospects for the development of therapeutic strategies for controlling HIV infection. The research findings appear in today's issue of the journal Nature Medicine.
Dr. Sékaly explained that "immune system cells made non-functional by HIV can be identified by the presence of a protein that is significantly overexpressed when infected by the virus." In fact, high levels of the protein are associated with a more serious dysfunction. "The most important discovery made in this study arises from the fact that by stimulating this protein, we succeeded in preventing the virus from making immune system cells dysfunctional," he added.
The findings were simultaneously reproduced by two other laboratories – the labs headed by Dr. Bruce Walker at Harvard and Dr. Richard Koup at the NIH. "It's a rare occurrence for three teams to work together on attacking a major problem. Up until now, the virus has been more or less invincible. By combining our efforts, we found the missing link that may enable us to defeat the virus," noted Dr. Sékaly. Discussions with partners are also underway to translate these research findings into clinical trials, which could start during the coming year.
Thanks to the joint efforts of the Université de Montréal, the CHUM Research Centre, Génome Québec, Genome Canada, the Canadian Institutes of Health Research (CIHR), the Canada Foundation for Innovation, the NIH, and the Fonds de la recherche en santé du Québec (FRSQ), Quebec continues to show great leadership in the life sciences.
Paul L'Archevêque and Martin Godbout, the presidents of Génome Québec and Genome Canada respectively, saluted the vision of the research team and the importance for Quebec and Canada of continuing to invest in genomics research. "The $14 million invested in this project certainly played a role in accelerating the researchers' work, and in helping Montreal to remain competitive on the international scene," noted the agency heads, adding that Dr. Sékaly's team was the first in the world to present the findings of this major study.
"The results of Dr. Sekaly's study represent an important step in the development of a new therapeutic approach in the fight against HIV," said Dr. Alan Bernstein, CIHR President. "This study is a compelling example of the excellence of Canadian health researchers and of Canada's contribution to the world's response to the HIV-AIDS pandemic."
"This important discovery is a powerful example of what can be achieved through partnership," added Dr. Eliot Phillipson, President and CEO of the Canada Foundation for Innovation. "Canada is proud to have researchers of Dr. Sékaly's calibre keeping our country at the forefront of the global fight against HIV-AIDS."
Dr. Mark Wainberg, Co-Director of the FRSQ-AIDS and infectious diseases Network and Co-Chair of the 16th World AIDS Conference held in Toronto last week, congratulated Dr. Sékaly and his team: "This scientific breakthrough is a giant step in the fight against AIDS. It is particularly interesting to see that some of the best research teams are working together to stop this terrible curse."
Sophie Langlois | EurekAlert!
Correct connections are crucial
26.06.2017 | Charité - Universitätsmedizin Berlin
One gene closer to regenerative therapy for muscular disorders
01.06.2017 | Cincinnati Children's Hospital Medical Center
An international team of scientists has proposed a new multi-disciplinary approach in which an array of new technologies will allow us to map biodiversity and the risks that wildlife is facing at the scale of whole landscapes. The findings are published in Nature Ecology and Evolution. This international research is led by the Kunming Institute of Zoology from China, University of East Anglia, University of Leicester and the Leibniz Institute for Zoo and Wildlife Research.
Using a combination of satellite and ground data, the team proposes that it is now possible to map biodiversity with an accuracy that has not been previously...
Heatwaves in the Arctic, longer periods of vegetation in Europe, severe floods in West Africa – starting in 2021, scientists want to explore the emissions of the greenhouse gas methane with the German-French satellite MERLIN. This is made possible by a new robust laser system of the Fraunhofer Institute for Laser Technology ILT in Aachen, which achieves unprecedented measurement accuracy.
Methane is primarily the result of the decomposition of organic matter. The gas has a 25 times greater warming potential than carbon dioxide, but is not as...
Hydrogen is regarded as the energy source of the future: It is produced with solar power and can be used to generate heat and electricity in fuel cells. Empa researchers have now succeeded in decoding the movement of hydrogen ions in crystals – a key step towards more efficient energy conversion in the hydrogen industry of tomorrow.
As charge carriers, electrons and ions play the leading role in electrochemical energy storage devices and converters such as batteries and fuel cells. Proton...
Scientists from the Excellence Cluster Universe at the Ludwig-Maximilians-Universität Munich have establised "Cosmowebportal", a unique data centre for cosmological simulations located at the Leibniz Supercomputing Centre (LRZ) of the Bavarian Academy of Sciences. The complete results of a series of large hydrodynamical cosmological simulations are available, with data volumes typically exceeding several hundred terabytes. Scientists worldwide can interactively explore these complex simulations via a web interface and directly access the results.
With current telescopes, scientists can observe our Universe’s galaxies and galaxy clusters and their distribution along an invisible cosmic web. From the...
Temperature measurements possible even on the smallest scale / Molecular ruby for use in material sciences, biology, and medicine
Chemists at Johannes Gutenberg University Mainz (JGU) in cooperation with researchers of the German Federal Institute for Materials Research and Testing (BAM)...
19.06.2017 | Event News
13.06.2017 | Event News
13.06.2017 | Event News
27.06.2017 | Earth Sciences
27.06.2017 | Earth Sciences
27.06.2017 | Life Sciences